Information on Third mRNA COVID-19 Vaccine Dose Added to NCCN Guidance for People With Cancer NCCN announced significant updates to the NCCN: Cancer and COVID-19 Vaccination guidance. This is the fourth version of NCCN’s COVID-19 vaccination
Search Results
Emily A. Harlan and Andrew G. Shuman
COVID-19 pandemic. 1 Drug shortages are a systematic problem: a manifestation of perverse incentives for pharmaceutical companies and other stakeholders, and of the fundamentally broken healthcare system in which we work. Drug shortages are often a
NCCN 2021 Virtual Annual Conference Addresses Cancer Care in a Year of Crisis and Innovation New recommendations to advance racial equity, ways to mitigate the impacts of the COVID-19 pandemic on cancer care, and ongoing strategies for
NCCN Updates Recommendations for COVID-19 Vaccination With Information on Bivalent Vaccines, Children With Cancer, and Other Developments NCCN has released updated recommendations from the NCCN Advisory Committee on COVID-19 Vaccination and
NCCN Cancer Experts Answer Questions About COVID-19 Vaccines NCCN has published new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new 4-page patient guide is based on the
Amye Tevaarwerk, Travis Osterman, Waddah Arafat, Jeffrey Smerage, Fernanda C.G. Polubriaginof, Tricia Heinrichs, Jessica Sugalski, and Daniel Martin
Introduction: The use of telemedicine in the oncology (Onc) setting expanded after March 2020 due to the COVID-19 pandemic. Patients and providers report satisfaction with telemedicine within the context of acute pandemic needs (Darcourt et al, JOP
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Alberto Delgado-Iribarren Garcia-Campero, Elvira Baos Muñoz, Sara Gil Useros, and Pedro Perez Segura
vaccine dose. Antibody titers were measured using the SARS-CoV-2 IgG II Quant assay. There was no possibility of collecting the samples within a prespecified window due to the strict COVID-19 restrictions which prevented the patients from attending to
William Alex Carson, Delecia Robinson, Lisa Scott, Tracie Lewis, Becky Eaddy, Annie Thibault, and Frank Berger
The COVID-19 shutdown halted elective procedures and limited in-person meetings, causing the Colorectal Cancer Prevention Network (CCPN) screening program to cease for 3 months. During this time, the CCPN focused on developing virtual patient
Updated Guidance for COVID-19 Vaccination From NCCN Recommends Fifth mRNA Shot (Second Booster Dose) for Immunocompromised People On April 27th, 2022, NCCN released the latest recommendations from the NCCN Advisory Committee on COVID-19
Protecting People With Cancer From COVID-19: New Recommendations From Cancer Guidelines Organization On January 4, 2022, NCCN published significant updates to the expert consensus recommendations on vaccination and pre-exposure prophylaxis of
